Long-Term Survivors Key to Halting AIDS Pandemic

August 18, 2006

UCSF AIDS researcher and co-discoverer of HIV, Jay Levy, MD, pioneered a study of long-term AIDS survivors, or "elite controllers," people who are infected with HIV but never get sick. The outcome Levy wants to see from studying elite controllers is a vaccine that induces this type of response.

Levy is professor in the Department of Medicine, research associate at the Cancer Research Institute, and director of the Laboratory of Tumor and AIDS Virus Research, all at UCSF.

Links:

"Long Term Survivors Key to Halting AIDS Pandemic"

HealthWatch, KPIX-TV (CBS 5), August 16, 2006

"UCSF Researcher Studying Population of Elite Controllers"
UCSF Today, August 18, 2006

Levy Lab

Explore UCSF News

IN MEMORIAM

UCSF ALS Center's Founding Director Dies of the Disease He Studied

CLINICAL RESEARCH

New Lung Cancer Test Predicts Survival

In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.

EDUCATION

UCSF's New Dean Wants to Raise Profile of Graduate Education

BIOINFORMATICS

UCSF School of Medicine Leaders Explore Bioinformatics

Bioinformatics was the focus of this year’s daylong UCSF School of Medicine leadership retreat on January 20. Campus leaders examined the question of how to optimally develop, organize and integrate clinical-outcome data, research data, business intelligence, and population data.